Z Latałło

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

The ɛ-(γ-Glutamyl)Lysine Crosslink and the Catalytic Role of Transglutaminases

The Immunopathology of Joint Inflammation in Rheumatoid Arthritis

Pharmacology and Management of the Vitamin K Antagonists

Sox9 Modulates Proliferation and Expression of Osteogenic Markers of Adipose-Derived Stem Cells (ASC)

Elevated D-dimer level is an independent risk factor for cardiovascular death in out-patients with symptoms compatible with heart failure

Role of the Catalytic Serine in the Interactions of Serine Proteinases with Protein Inhibitors of the Serpin Family

NMR solution structure of the recombinant tick anticoagulant protein (rTAP), a factor Xa inhibitor from the tick Ornithodoros moubata

Association Between CYP2C9 Genetic Variants and Anticoagulation-Related Outcomes During Warfarin Therapy

Antithrombotic Therapy for VTE Disease

Hyaluronan: from extracellular glue to pericellular cue

The pH Dependence of Serpin-Proteinase Complex Dissociation Reveals a Mechanism of Complex Stabilization Involving Inactive and Active Conformational States of the Proteinase Which Are Perturbable by Calcium

Isolation of Angiopoietin-1, a Ligand for the TIE2 Receptor, by Secretion-Trap Expression Cloning

The molecular basis of blood coagulation

Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein

Evolving concepts of rheumatoid arthritis

Antithrombotic Therapy for VTE Disease

Recent advances with liposomes as pharmaceutical carriers

A Controlled Trial of Tranexamic Acid Therapy for the Reduction of Bleeding During Treatment of Acute Myeloid Leukemia

The coagulation cascade: initiation, maintenance, and regulation

TEMPO-oxidized cellulose nanofibers

Oral Anticoagulants

Endocrine Regulation of Energy Metabolism by the Skeleton

Resistance to Activated Protein C as a Basis for Venous Thrombosis

Fibrinogen depleting agents for acute ischaemic stroke

Oral Anticoagulants: Mechanism of Action, Clinical Effectiveness, and Optimal Therapeutic Range

Disseminated Intravascular Coagulation

Antithrombotic Therapy for Venous Thromboembolic Disease

Substrate-Assisted Catalysis of the PAR1 Thrombin Receptor

Fortnightly Review: Disseminated intravascular coagulation: diagnosis and treatment

Molecular cloning and expression of human hepatocyte growth factor

Guidelines for the Early Management of Adults With Ischemic Stroke

Rapid Thrombolysis and Preservation of Valvular Venous Function in High Deep Vein Thrombosis

Extracellular DNA traps promote thrombosis

Guidelines for the Early Management of Patients With Acute Ischemic Stroke

Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial

Protease-activated receptor 1 (PAR1) signalling desensitization is counteracted via PAR4 signalling in human platelets

3. IDENTIFICATION AND PURIFICATION OF FIBRINOGEN DEGRADATION PRODUCTS PRODUCED BY PLASMIN: CONSIDERATIONS ON THE STRUCTURE OF FIBRINOGEN

All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I. Clinical results [see comments]

The role of granulocytes in the activation of intravascular coagulation and the precipitation of soluble fibrin by endotoxin

Mechanism of Acceleration of Antithrombin-Proteinase Reactions by Low Affinity Heparin

Subunit structure of the plasmin-induced degradation products of crosslinked fibrin

Coronary arterial thrombolysis with combined infusion of recombinant tissue-type plasminogen activator and urokinase in patients with acute myocardial infarction.

Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells

FIBRINOGEN AND FIBRIN

Evaluation of combination thrombolytic therapy and timing of cardiac catheterization in acute myocardial infarction. Results of thrombolysis and angioplasty in myocardial infarction--phase 5 randomized trial. TAMI Study Group.

Serpin Structure, Mechanism, and Function

Effects of Disruption of The Plasminogen Gene on Thrombosis, Growth, and Health in Mice

Structure of a cytotoxic T-lymphocyte-specific gene shows a strong homology to fibrinogen beta and gamma chains.

PROSTACYCLIN CAN REPLACE HEPARIN IN HÆMODIALYSIS IN DOGS

Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia [see comments]

American Heart Association/American College of Cardiology Foundation Guide to Warfarin Therapy

Fibrinogen depleting agents for acute ischaemic stroke

Long-term anticoagulant therapy after acute myocardial infarction

Precipitation of fibrinogen, fibrinogen degradation products and fibrin monomer by histone H3

Hyaluronan stimulates tumor cell migration by modulating the fibrin fiber architecture

FIBRIN ASSEMBLY*

Mechanisms of adenosine triphosphate-, thrombin-, and trypsin-induced relaxation of rat thoracic aorta.

Tumor necrosis factor increases the production of plasminogen activator inhibitor in human endothelial cells in vitro and in rats in vivo

Thrombocytosis in patients with tumors producing colony-stimulating factor

Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia

ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

High Molecular Weight Derivatives of Human Fibrinogen Produced by Plasmin

American Heart Association/American College of Cardiology Foundation guide to warfarin therapy11The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel. Specifically, all members of the writing group are required to complete and submit a Disclosure Questionnaire showing all such relationships that might be perceived as real or potential conflicts of interest.This statement has been co-published in the April 1, 2003, issue of Circulation.This statement was approved by the American Heart Association Science Advisory and Coordinating Committee in October 2002 and by the American College of Cardiology Board of Trustees in February 2003. A single reprint is available by calling 800-242-8721 (US only) or writing the American Heart Association, Public Information, 7272 Greenville Ave, Dallas, TX 75231-4596. Ask for reprint No. 71-0254. To purchase additional reprints: up to 999 copies, call 800-611-6083 (US only) or fax 413-665-2671; 1000 or more copies, call 410-528-4426, fax 410-528-4264, or e-mail klbradle@lww.com. To make photocopies for personal or educational use, call the Copyright Clearance Center, 978-750-8400.

A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test)

Antigenic and antiheparin properties of human platelet factor 4 (PF4)

Human Factor XIII from Plasma and Platelets

The Effect of Plasmin on the Subunit Structure of Human Fibrinogen

Vasodilatation in the Canine Leg caused by Intra-arterial Infusion of Thrombin and Tissue Thromboplastin

Studies on synthetic peptides that bind to fibrinogen and prevent fibrin polymerization. Structural requirements, number of binding sites, and species differences

Predominant contribution of surface approximation to the mechanism of heparin acceleration of the antithrombin-thrombin reaction. Elucidation from salt concentration effects.

Hydroxyl radical-modified fibrinogen as a marker of thrombosis: the role of iron

Posttranslational processing of the LDL receptor and its genetic disruption in familial hypercholesterolemia

Mass–length ratio of fibrin fibers from gel permeation and light scattering

Optimal Therapeutic Range for Oral Anticoagulants

An International Randomized Trial Comparing Four Thrombolytic Strategies for Acute Myocardial Infarction

Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

Thrombolytic Treatment with Tissue-type Plasminogen Activator (t-PA) Containing Liposomes in Rabbits: a Comparison with Free t-PA

The Essential Covalent Structure of Human Fibrinogen Evinced by Analysis of Derivatives Formed during Plasmic Hydrolysis

Is the Dose of Warfarin Prescribed by American Physicians Unnecessarily High?

Endothelial cells in physiology and in the pathophysiology of vascular disorders.

Tumors: Wounds That Do Not Heal

cDNA isolated from a human T-cell library encodes a member of the protein-tyrosine-phosphatase family.

2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease

Development of a Point of Care Lateral Flow Device for Measuring Human Plasma Fibrinogen

The Use of Soluble Fibrin in Evaluating the Acute and Chronic Hypercoagulable State

Subunit Structure of Fragment D from Fibrinogen and Cross-Linked Fibrin

Argatroban Anticoagulant Therapy in Patients With Heparin-Induced Thrombocytopenia

Fibrinolysis and fibrinogenolysis by Val442-plasmin

Acute Promyelocytic Leukemia: Results of Treatment by Daunorubicin

Isolation and characterization of the clottable low-molecular-weight fibrinogen derived by limited plasmin hydrolysis of human fraction I-4

The Effect of Low-Dose Warfarin on the Risk of Stroke in Patients with Nonrheumatic Atrial Fibrillation

Platelet Function in Patients with High Platelet Counts

The role of fragment X polymers in the fibrin enhancement of tissue plasminogen activator-catalyzed plasmin formation.

Thrombocytosis in patients with tumors producing colony-stimulating factor

Plasmic degradation of bovine fibrinogen and non-cross-linked fibrins in solution and in gel form

The Caenorhabditis elegans cell death gene ced-4 encodes a novel protein and is expressed during the period of extensive programmed cell death

The Defibrination Syndrome: Clinical Features and Laboratory Diagnosis

Inhibition of Thrombin and of Fibrin Polymerization, Two Activities derived from Plasmin-digested Fibrinogen

Inhibition of Platelet Aggregation by Dialysable Fibrinogen Degradation Products (FDP)

Studies on the Molecular Pathology and Pathogenesis of Bleeding in Severe Fibrinolytic States in Dogs

Characterisation of large fragments rich in disulphide bridges from CNBr-treated products of exhaustive proteolysis of fibrinogen by plasmin

An Evaluation of Chromogenic Substrates in the Control of Oral Anticoagulant Therapy

Retrospective Study on Complications and Adverse Effects of Treatment with Thrombin-Like Enzymes - A Multicentre Trial

Precipitation of Soluble Fibrin Monomer Complexes SFMC by Cellular Basic Proteins, and the Antagonistic Effect of Sulfonated Mucopolysaccharides

Reaction of thrombins with human antithrombin III I. Enzyme activity losses unrelated to the inhibitory reaction and their prevention

Circulating Fibrinogen Degradation Products (FDP) in Dog Blood after Intravenous Thrombin Infusion

Plasminogen assay in rabbit, rat and mouse plasma using the chromogenic substrate S-2251

High molecular weight products of the late stage of fibrinogen proteolysis by plasmin and their structural relation to the fibrinogen molecule

Soluble Unclottable Complexes Formed in the Presence of Fibrinogen Degradation Products (FDP) during the Fibrinogen-Fibrin Conversion and Their Potential Significance in Pathology

The effect of proteolytic enzymes on fibrin stabilizing factor

6. FORMATION OF SOLUBLE FIBRIN COMPLEXES AND SOME FACTORS AFFECTING THEIR SOLUBILITY

Influence of pH, ionic strength, neutral ions, and thrombin on fibrin polymerization

2. DEGRADATION OF FIBRINOGEN BY PROTEOLYTIC ENZYMES

Inhibition of fibrin polymerization by fibrinogen proteolysis products

Coagulation Disorders in Thrombocythaemia, a Study of Seven Cases

19. EFFECT OF PROTAMINE SULPHATE ON THE SOLUBILITY OF FIBRINOGEN, ITS DERIVATIVES AND OTHER PLASMA PROTEINS

Studies on the “double D” fragment from stabilized bovine fibrin

4. A POSSIBLE RELATION BETWEEN THE LOCATION OF D AND E FRAGMENTS AND OF THE N‐TERMINAL DISULPHIDE KNOTS IN FIBRINOGEN MOLECULE

Characterisation and comparison of macromolecular end products of fibrinogen and fibrin proteolysis by plasmin

54. SIMPLE AND RAPID EVALUATION OF THE INTRAVASCULAR COAGULATION AND FIBRINOLYTIC STATES BY APPLICATION OF PROTAMINE SULPHATE AND REPTILASE R